期刊
PATHOLOGY & ONCOLOGY RESEARCH
卷 28, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/pore.2022.1610378
关键词
breast cancer; radiotherapy; guidelines; radiation oncology; consensus
资金
- Central-Eastern European Academy of Oncology (CEEAO)
- National Institute of Oncology, Hungary
- Bacs-Kiskun County Teaching Hospital
The international radiotherapy expert panel has revised and updated the guidelines for radiotherapy in breast cancer based on new scientific evidence. Radiotherapy plays a crucial role in reducing the risk of local recurrence in breast cancer.
The international radiotherapy (RT) expert panel has revised and updated the RT guidelines that were accepted in 2020 at the 4th Hungarian Breast Cancer Consensus Conference, based on new scientific evidence. Radiotherapy after breast-conserving surgery (BCS) is indicated in ductal carcinoma in situ (stage 0), as RT decreases the risk of local recurrence (LR) by 50-60%. In early stage (stage I-II) invasive breast cancer RT remains a standard treatment following BCS. However, in elderly (& GE;70 years) patients with stage I, hormone receptor-positive tumour, hormonal therapy without RT can be considered. Hypofractionated whole breast irradiation (WBI) and for selected cases accelerated partial breast irradiation are validated treatment alternatives to conventional WBI administered for 5 weeks. Following mastectomy, RT significantly decreases the risk of LR and improves overall survival of patients who have 1 to 3 or & GE;4 positive axillary lymph nodes. In selected cases of patients with 1 to 2 positive sentinel lymph nodes axillary dissection can be substituted with axillary RT. After neoadjuvant systemic treatment (NST) followed by BCS, WBI is mandatory, while after NST followed by mastectomy, locoregional RT should be given in cases of initial stage III-IV and ypN1 axillary status.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据